Position in AXGN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,686,776
+$740,487 QoQ
Shares Held
81,098
+36.4% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026B. Metzler seel. Sohn & Co. AG holds $256,550,782 across 14 Medical Devices names. AXGN ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
1,824,388 | $187,309,914 | |
| 2 | SYK |
Stryker Corp
|
79,355 | $26,075,258 | |
| 3 | BSX |
Boston Scientific Corp
|
265,133 | $16,637,095 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
88,014 | $6,264,836 | |
| 5 | EW |
Edwards Lifesciences Corp
|
56,017 | $4,485,841 | |
| 6 | DXCM |
Dexcom Inc
|
46,347 | $2,910,591 | |
| 7 | AXGN |
Axogen, Inc.
This page
|
81,098 | $2,686,776 | |
| 8 | GMED |
Globus Medical Inc
|
30,655 | $2,641,234 |
All Filings in AXGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,686,776 | 81,098 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,946,289 | 59,465 | Shares | Defined | 2026-01-28 | |
| No filing history on record for this holder in this stock. | ||||||